45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
12,618
Insurances with rates
16
CPT / HCPCS codes
10,654
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $329,498 | $97,531 | $197,699 | $266,893 | 6 |
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $329,498 | $97,531 | $433 | $266,893 | 25 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $296,910 | $87,885 | $178,146 | $240,497 | 6 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $296,910 | $87,885 | $422 | $240,497 | 13 |
| J9321 | EPCORITAMAB-BYSP 0.16 MG/ML SUBCUTANEOUS SOLUTION | $285,934 | $84,636 | $171,560 | $231,606 | 6 |
| J9321 | EPCORITAMAB-BYSP 0.16 MG/ML SUBCUTANEOUS SOLUTION | $285,934 | $84,636 | $42,890 | $231,606 | 13 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $188,179 | $55,701 | $112,908 | $152,425 | 6 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $188,179 | $55,701 | $28,227 | $152,425 | 13 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $163,667 | $48,445 | $98,200 | $132,570 | 6 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $163,667 | $48,445 | $2,376 | $132,570 | 25 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $142,346 | $42,134 | $85,408 | $115,300 | 6 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $142,346 | $42,134 | $51.68 | $115,300 | 25 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $136,980 | $40,546 | $82,188 | $110,954 | 6 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $136,980 | $40,546 | $20,547 | $110,954 | 25 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $122,923 | $36,385 | $73,754 | $99,567 | 6 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $122,923 | $36,385 | $315 | $99,567 | 25 |
| 0408T | INSERT/REPL PCCM SYS | $113,970 | $33,735 | $92,316 | $92,316 | 3 |
| 0408T | INSERT/REPL PCCM SYS | $113,970 | $33,735 | $0.65 | $92,316 | 26 |
| 33289 | IMPT WIRELESS PULM/ART SENSOR | $110,250 | $32,634 | $89,303 | $89,303 | 3 |
| 33289 | IMPT WIRELESS PULM/ART SENSOR | $110,250 | $32,634 | $0.65 | $89,303 | 26 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $102,229 | $30,260 | $61,337 | $82,805 | 6 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $102,229 | $30,260 | $198 | $82,805 | 25 |
| J8499 | NINTEDANIB 150 MG CAPSULE | $91,485 | $27,080 | $54,891 | $74,103 | 6 |
| J8499 | NINTEDANIB 150 MG CAPSULE | $91,485 | $27,080 | $13,723 | $74,103 | 13 |
| 33249 | HC INSERT ICD+LEAD SNGL/DUAL | $89,681 | $26,546 | $72,642 | $72,642 | 3 |
| 33249 | HC INSERT ICD+LEAD SNGL/DUAL | $89,681 | $26,546 | $0.65 | $72,642 | 27 |
| 93653 | HC EP&ABLATE SUPRAVENT ARRHYT | $83,880 | $24,828 | $67,943 | $67,943 | 3 |
| 93653 | HC EP&ABLATE SUPRAVENT ARRHYT | $83,880 | $24,828 | $167 | $67,943 | 26 |
| 93654 | HC EP&ABLATE VENTRIC TACHY | $83,880 | $24,828 | $67,943 | $67,943 | 3 |
| 93654 | HC EP&ABLATE VENTRIC TACHY | $83,880 | $24,828 | $167 | $67,943 | 26 |
| 93656 | HC TX ATRIAL FIB PULM VEIN ISOL | $83,880 | $24,828 | $67,943 | $67,943 | 3 |
| 93656 | HC TX ATRIAL FIB PULM VEIN ISOL | $83,880 | $24,828 | $167 | $67,943 | 26 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $83,630 | $24,754 | $50,178 | $67,740 | 6 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $83,630 | $24,754 | $12,544 | $67,740 | 13 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $83,377 | $24,680 | $50,026 | $67,535 | 6 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $83,377 | $24,680 | $223 | $67,535 | 25 |
| 36906 | AV-THROMBECT W/STNT PERIPH DYL | $83,126 | $24,605 | $67,332 | $67,332 | 3 |
| 36906 | AV-THROMBECT W/STNT PERIPH DYL | $83,126 | $24,605 | $0.65 | $67,332 | 26 |
| 33276 | INST PHRNC NRV STIM SYS | $81,705 | $24,185 | $66,181 | $66,181 | 3 |
| 33276 | INST PHRNC NRV STIM SYS | $81,705 | $24,185 | $5,079 | $66,181 | 8 |
| 0409T | INSERT/REPL PULSE GEN ONLY | $81,660 | $24,171 | $66,145 | $66,145 | 3 |
| 0409T | INSERT/REPL PULSE GEN ONLY | $81,660 | $24,171 | $0.65 | $66,145 | 26 |
| 0414T | REMO/REPL PCCM GEN ONLY | $81,660 | $24,171 | $66,145 | $66,145 | 3 |
| 0414T | REMO/REPL PCCM GEN ONLY | $81,660 | $24,171 | $0.65 | $66,145 | 26 |
| 33270 | HC INS/REP SUBC DEFIBRILLATOR | $78,718 | $23,301 | $63,762 | $63,762 | 3 |
| 33270 | HC INS/REP SUBC DEFIBRILLATOR | $78,718 | $23,301 | $0.65 | $70,193 | 26 |
| J9022 | ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $78,265 | $23,167 | $46,959 | $63,395 | 6 |
| J9022 | ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $78,265 | $23,167 | $79.92 | $63,395 | 25 |
| J9144 | DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN | $77,627 | $22,978 | $46,576 | $62,878 | 6 |
| J9144 | DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN | $77,627 | $22,978 | $47.38 | $62,878 | 25 |
Showing top 50 of 12,618 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.